AstraZeneca, Merck ovarian cancer treatment improves progression-free survival

AstraZeneca, Merck ovarian cancer treatment improves progression-free survival
Reuters: Health
AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian